首页> 外文OA文献 >Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study

【2h】

Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study

机译：在临床和替代成果的基础上，加拿大卫生批准的药物批准的毒品：队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. Lexchin; T. Ahmed;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study [J] . Joel Lexchin BMJ Open . 2014,第2期

机译：加拿大的上市后安全性：重要的治疗进展和生物制剂的安全性是否低于其他药物？队列研究
2. How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study [J] . Joel Lexchin Healthcare policy . 2016,第2期

机译：一项加拿大卫生部批准的一流药物如何安全和具有创新性
3. Adverse pregnancy outcomes between the anti-malarial drugs: Is there a difference between the drugs recommended by World Health Organization? Results of a mixed treatment comparison analysis of randomized clinical trials and cohort studies [J] . Kannan Sridharan, Gowri Sivaramakrishnan Steve Kanters The International journal of risk & safety in medicine. . 2019,第2期

机译：抗疟疾药物之间的不良妊娠结果：世界卫生组织推荐的药物之间有差异吗？随机临床试验和队列研究的混合处理比较分析结果
4. A Novel Approach to Examining Multiple Indoor Exposures in Early Childhood on the Inflammatory Pathway and Risk of Intermediate Outcomes for Childhood Asthma in the Canadian Healthy Infant Longitudinal Development (CHILD) Birth Cohort [C] . Tim K. Takaro, Martine Vrijheid, Xavier Basagana, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：在加拿大健康婴儿纵向发育（CHILD）队列研究中，研究了多种早期途径，研究了早期炎症途径上的多个室内暴露以及儿童哮喘中级结局的风险
5. Impact of FDAAA on Registration, Results Reporting, and Publication of Clinical Trials Evaluating New Neuropsychiatric Drugs Approved Between 2005 and 2014 [D] . Zou, Constance Xuanyi. 2019

机译：FDAAA对注册，结果报告和发表临床试验的影响，评估2005年至2014年批准的新神经精神药物
6. Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study [O] . Joel Lexchin, Tareq Ahmed 2015

机译：加拿大卫生部根据临床和替代结果批准的药品上市后安全性：一项队列研究
7. Publication of confirmatory studies required by Health Canada for drugs approved under a Notice of Compliance with conditions: a cohort study [O] . Joel Lexchin 2017

机译：发表卫生加拿大卫生所需的确认研究，以便在遵守条件的通知下批准的药物：队列研究
8. New Drug Approval: FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints [R] . 2009

机译：新药批准：FDa需要加强对基于代理终点批准的药物的监督

Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study

著录项

引文网络

相似文献

相关主题

期刊订阅